Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-4840

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-4840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 4840 9)

Pdp (68071 4840 9)
The text seems to be a medicine label. The drug mentioned is Atorvastatin Calcium, presumably available in the form of tablets. The label also denotes the strength of the medicine to be 20mg. There is a warning to keep the medicine out of reach of children and to store it within the specified temperature range. The medicine is manufactured and packed by different companies with their respective lot and NDC numbers. Overall, the text appears to be a description of a medicine composition and its manufacturing and storage details.*
FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

Atorvastatin-fig-1 (Atorvastatin Fig 1)
Not available.*
FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Atorvastatin-fig-2 (Atorvastatin Fig 2)
This is a chart or graph representing the cumulative hazard percentage of a placebo and Atorvastatin over a 4-year follow-up period. The hazard ratio (HR) of Atorvastatin is given as 0.63, with a confidence interval (0.48-0.83) and a p-value of 0.001. The x-axis shows the time to the first primary endpoint, while the y-axis represents the cumulative hazard percentage.*
FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

Atorvastatin-fig-3 (Atorvastatin Fig 3)
This is a statistical analysis of the effectiveness of Atorvastatin at different dosages in preventing major cardiovascular events over time. The table shows the percentage of subjects who experienced the events and the corresponding dosage. The results indicate that the 80 mg dose of Atorvastatin is more effective in preventing cardiovascular events compared to the 10 mg dose, with a hazard ratio of 0.78 (95% confidence interval of 0.69-0.89, p=0.0002). The time to the first major cardiovascular endpoint is shown in years.*
FDA Label Image

Atorvastatin-st (Atorvastatin St)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.